fightcancer.co.nz valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title Cancer Immunotherapy in New Zealand | Fight Cancer
Description Treatment with Find out about a treatment option for cancers such as melanoma, non-small cell lung cancer, oesophageal cancer, renal cell carcinoma, and
Keywords N/A
Server Information
WebSite fightcancer faviconfightcancer.co.nz
Host IP 75.2.28.153
Location United States
Related Websites
Site Rank
More to Explore
fightcancer.co.nz Valuation
US$1,344,162
Last updated: 2023-05-11 18:03:41

fightcancer.co.nz has Semrush global rank of 7,874,278. fightcancer.co.nz has an estimated worth of US$ 1,344,162, based on its estimated Ads revenue. fightcancer.co.nz receives approximately 155,096 unique visitors each day. Its web server is located in United States, with IP address 75.2.28.153. According to SiteAdvisor, fightcancer.co.nz is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,344,162
Daily Ads Revenue US$1,241
Monthly Ads Revenue US$37,223
Yearly Ads Revenue US$446,676
Daily Unique Visitors 10,340
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
fightcancer.co.nz. A 300 IP: 75.2.28.153
fightcancer.co.nz. A 300 IP: 99.83.146.123
fightcancer.co.nz. NS 86400 NS Record: ns-1313.awsdns-36.org.
fightcancer.co.nz. NS 86400 NS Record: ns-1882.awsdns-43.co.uk.
fightcancer.co.nz. NS 86400 NS Record: ns-420.awsdns-52.com.
fightcancer.co.nz. NS 86400 NS Record: ns-734.awsdns-27.net.
fightcancer.co.nz. TXT 300 TXT Record: google-site-verification=qPUTjQswOvxofBMNK6GsDF-F_YGD2grZB2ik_KpdHyQ
fightcancer.co.nz. TXT 300 TXT Record: v=spf1 -all
fightcancer.co.nz. TXT 300 TXT Record: 9g5y075x7zrx46gd6sfbyb92k280st63
HtmlToTextCheckTime:2023-05-11 18:03:41
Types of Cancer Melanoma Lung cancer Classical Hodgkin lymphoma Urothelial carcinoma including bladder cancer Head and neck squamous cell cancer MSI-H/dMMR cancer Renal cell carcinoma Oesophageal cancer Endometrial carcinoma Triple-negative breast cancer Cervical cancer Understanding Immunotherapy About KEYTRUDA Access KEYTRUDA For Healthcare Professionals Treatment with KEYTRUDA KEYTRUDA may be used to treat patients with certain types of cancer. It is known as an immunotherapy and works by helping your immune system detect and fight your cancer. Read more KEYTRUDA may be used to treat patients with the following types of cancers Melanoma Melanoma KEYTRUDA is funded (restrictions apply), in adults with melanoma that has spread or cannot be removed by surgery. KEYTRUDA may be used, but is not funded, in certain adults and children with melanoma given after surgery to prevent the cancer from coming back. Read more Non-small cell lung cancer Non-small cell lung cancer KEYTRUDA is funded
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: awselb/2.0
Date: Tue, 09 Nov 2021 09:00:49 GMT
Content-Type: text/html
Content-Length: 134
Connection: keep-alive
Location: https://www.fightcancer.co.nz:443/

HTTP/2 200 
content-type: text/html;charset=UTF-8
date: Tue, 09 Nov 2021 09:00:50 GMT
set-cookie: AWSALBTG=qvnvuUPmjJtNnwMFlFBVNqzYXdS0AfgqUy7gZ3rMnr7Iu3yY9lH44tiy7f83+yApVxHNCjXBYPZ+OjdTn1igUkznT4PbiG75evk1fOoT/Xs5o2nMX8BJFqbqUbZwStdq7UpWRjTIXinuoBs5EOlnNCktsk9VHMppXkj5QAIeDsY9bt0Igig=; Expires=Tue, 16 Nov 2021 09:00:50 GMT; Path=/
set-cookie: AWSALBTGCORS=qvnvuUPmjJtNnwMFlFBVNqzYXdS0AfgqUy7gZ3rMnr7Iu3yY9lH44tiy7f83+yApVxHNCjXBYPZ+OjdTn1igUkznT4PbiG75evk1fOoT/Xs5o2nMX8BJFqbqUbZwStdq7UpWRjTIXinuoBs5EOlnNCktsk9VHMppXkj5QAIeDsY9bt0Igig=; Expires=Tue, 16 Nov 2021 09:00:50 GMT; Path=/; SameSite=None; Secure
set-cookie: AWSALB=2okIkauO4ApnoBFRjqm7XCzhvsBOSHtk3DgCIKWTKxVyANK5f/tIOI2jLA8/sgiCDO/PwCqDjuIvKbGfgBgC69GLbiPsWeQ1TfQbKZhRioZimFhRRUV1JYuOO8X/; Expires=Tue, 16 Nov 2021 09:00:50 GMT; Path=/
set-cookie: AWSALBCORS=2okIkauO4ApnoBFRjqm7XCzhvsBOSHtk3DgCIKWTKxVyANK5f/tIOI2jLA8/sgiCDO/PwCqDjuIvKbGfgBgC69GLbiPsWeQ1TfQbKZhRioZimFhRRUV1JYuOO8X/; Expires=Tue, 16 Nov 2021 09:00:50 GMT; Path=/; SameSite=None; Secure
server: Apache
x-frame-options: SAMEORIGIN, SAMEORIGIN
referrer-policy: origin-when-cross-origin
feature-policy: vibrate 'none'
vary: Referer,Accept-Encoding
cache-control: private, no-store, no-cache, must-revalidate
pragma: no-cache
expires: Thu, 01 Jan 1970 00:00:00 GMT
set-cookie: JSESSIONID=100BF88B6BE02D5F743DB09B01EBFACB; Path=/; Secure; HttpOnly
set-cookie: svcacess=a0df87f03eeeae3cc6a7d4b0115f2dfc; Path=/; Secure
x-xss-protection: 1; mode=block
x-content-type-options: nosniff
set-cookie: oam.Flash.RENDERMAP.TOKEN=-m7kist3kg; Path=/foundation
content-security-policy: frame-ancestors 'self' *.epublishmerck.com facebook.com;
strict-transport-security: max-age=31536000
x-cache: Miss from cloudfront
via: 1.1 dad289b00682a96e4153dd7ef9e7def3.cloudfront.net (CloudFront)
x-amz-cf-pop: ORD53-C3
x-amz-cf-id: k4er8BCCZTf3MM_LsaKN65QOJDCtbBE1DkWu55tiavK3YVVJVE6x4Q==
fightcancer.co.nz Whois Information
version: 8.7
query_datetime: 2021-11-09T21:52:31+13:00
domain_name: fightcancer.co.nz
query_status: 200 Active
domain_dateregistered: 2016-02-05T11:21:52+13:00
domain_datelastmodified: 2021-01-03T23:08:32+13:00
domain_datecreated: 2016-02-05T11:21:52+13:00
domain_delegaterequested: yes
domain_signed: no
registrar_name: MarkMonitor Inc.
registrar_address1: 2150 S Bonito Way
registrar_address2: Suite 150
registrar_city: Meridian
registrar_province: Idaho
registrar_postalcode: 83642
registrar_country: US (UNITED STATES)
registrar_phone: +1 208 3895740
registrar_fax: +1 208 3895771
registrar_email: ccops@markmonitor.com
ns_name_01: ns-734.awsdns-27.net
ns_name_02: ns-1313.awsdns-36.org
ns_name_03: ns-1882.awsdns-43.co.uk
ns_name_04: ns-420.awsdns-52.com